v3.26.1
Segment Information - Significant expense categories that are regularly reported to the chief operating decision maker (Details) - Reportable Segment [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting Information [Line Items]        
Revenue $ 150 $ 221 $ 376 $ 451
Net loss before noncontrolling interest (46,436) (36,965) (89,057) (74,917)
Clinical trial expense        
Segment Reporting Information [Line Items]        
Other Expenses 14,185 7,188 27,346 14,711
Cash compensation        
Segment Reporting Information [Line Items]        
Other Expenses 13,316 13,811 27,545 27,064
Cash operating expenses        
Segment Reporting Information [Line Items]        
Other Expenses 13,705 11,595 24,560 24,739
Other segment items        
Segment Reporting Information [Line Items]        
Other Expenses [1] $ 5,380 $ 4,592 $ 9,982 $ 8,854
[1] Other segment items primarily include interest income, equity-based compensation and depreciation.